Delivery Order SPE2DB22D2206-SPE2DB25FJK95
Award Date 8/14/25
Potential Completion Date 9/5/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $93,868.32 by the Defense Logistics Agency's Medical Supply Chain for the supply of Xeomin 200 Unit Vials. The contract, awarded on August 7, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 28, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xeomin 50 unit vials valued at $10,941.84. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit vials. This competitively awarded, firm fixed price contract was issued on August 27, 2025, with an ultimate completion date of September 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a non-set-aside procurement, this delivery order was competed among qualified...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,174.80 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Xeomin 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a non-competitive set-aside award. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xeomin 200 unit vials valued at $46,934.16. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 3, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic applications. This $10,057.32 firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 22, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $23,467.08 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $93,868.32 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, for the supply of Xeomin 100 Unit vials. The contract ceiling value is $11,174.80, with an ultimate completion date of September 12, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.85 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a prescription medication used for treating muscle spasticity and other therapeutic indications. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...